KAYA
|
|
BOM : 539276     NSE : KAYA     | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward Pledged Shares : None or < 25% |
May 26,2023 |
Price(EOD): βΉ 328.70
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: βΉ 430.60 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
KAYA | -4.4% | 7.2% | 3.5% |
APOLLO HOSPITALS ENTERPRISE | -0% | 4.5% | 22.8% |
MAX HEALTHCARE INSTITUTE | -2.4% | 22.4% | 46.7% |
FORTIS HEALTHCARE | 0.7% | 11.1% | 18.3% |
DR LAL PATHLABS | 0.3% | 4.9% | 2.3% |
NARAYANA HRUDAYALAYA | 1.6% | 11.8% | 35.8% |
KRISHNA INSTITUTE OF MEDICAL SCIENCES | 0.8% | 8.5% | 24.9% |
ASTER DM HEALTHCARE | 5% | 8.5% | 59.1% |
RAINBOW CHILDRENS MEDICARE | 4.5% | 20.6% | 106% |
FUNDAMENTAL ANALYSIS OF KAYA
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF KAYA
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
-3.69
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -116.26 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] -151.2
P/B Calculated based on Book Value of Rs -2.84 Cr
[Latest Year - Mar2022 - Consolidated Results ] 1.14
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 376.73 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
498% -51% -53% |
SHARE PRICE MOMENTUM OF KAYA
KAYA vs SENSEX
DEBT OF KAYA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.88 0.21 0.08 0.39 |
-30.33 0.66 0.37 -9.77 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF KAYA
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF KAYA
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-7.4% -1259.18% -217.19% -217.19% |
10.92% -16.03% -36.33% -36.33% |
QtrlyTrend |
-6 | |
Latest Qtr: Mar2023 | ||
Quarterly Result Analysis → |
KAYA related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE CONSUMER DISC. | 2.1% | 8% | 16% |
S&P BSE MIDSMALLCAP | 2% | 6.8% | 16.6% |
S&P BSE ALLCAP | 1.9% | 5% | 12.9% |
S&P BSE SMALL CAP | 1.4% | 6.3% | 14.5% |
You may also like the below Video Courses
FAQ about KAYA
Is KAYA good for long term investment?
As on May 26,2023, the Fundamentals of KAYA look Poor and hence it may not be good for long term investment ! See Financial Performance of KAYA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is KAYA UnderValued or OverValued?
As on May 26,2023, KAYA is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of KAYA ?
As on May 26,2023, the Intrinsic Value of KAYA is Rs. 665.53 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 54.98
Fair Value [Median EV / Sales Model] : Rs. 665.53
Fair Value [Median Price / Sales Model] : Rs. 706.28
Estimated Median Fair Value of KAYA : Rs. 665.53
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is KAYA trading at a Premium or Discount?
As on May 26,2023, KAYA is trading at a Discount of -51% based on the estimates of Median Intrinsic Value!